Versartis Long-Term Safety Study of Somavaratan

Clinical trial NCT02068521 · TERMINATED

Trial details

NCT number: NCT02068521
Sponsor: Versartis Inc.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2014-03-03
Primary completion: 2017-11-17
Enrollment: 385

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.